表紙:補助人工心臓の世界市場-2023年~2030年
市場調査レポート
商品コード
1373387

補助人工心臓の世界市場-2023年~2030年

Global Ventricular Assist Devices Market - 2023-2030

出版日: | 発行: DataM Intelligence | ページ情報: 英文 185 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.08円
補助人工心臓の世界市場-2023年~2030年
出版日: 2023年10月18日
発行: DataM Intelligence
ページ情報: 英文 185 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

概要

補助人工心臓(VAD)は、心臓が弱っている人や機能が低下している人の心臓機能と血流をサポートするために使用される機械式ポンプです。補助人工心臓は、機能不全に陥った心臓の機能を部分的または完全に代替するために使用されます。

補助人工心臓は、右心室(RVAD)または左心室(LVAD)、あるいは両心室(BiVAD)を補助するように設計されています。心臓の仕事量を軽減することで、補助人工心臓は寿命を延ばし、疲労や息苦しさなどの症状を改善することができます。

市場力学:市場促進要因と市場抑制要因

心疾患と心不全負担の増加

心疾患の増加と心不全負担の増加が市場成長の原動力になると予想されます。これらの要因は補助人工心臓の需要を増加させる。さらに、技術的進歩の増加やデバイスの承認の増加も市場を牽引すると予想されます。

例えば、2022年に発表された報告書によると、心不全の有病率は世界で2,600万人と推定されており、世界のヘルスケアコストの増加に寄与しています。心不全は、高い罹患率と死亡率を伴う疾患として、世界的に依然として高い頻度で蔓延しています。

さらに、Journal of the American College of Cardiology誌に掲載された報告書によると、収縮期血圧の高値は、2021年に約1,080万人の心血管疾患死、全体で約1,130万人の死亡となった帰属的早期心血管死の世界の主要な修正可能危険因子であり続け、特に虚血性心疾患と脳卒中関連死との関連が指摘されています。したがって、上記の要因が予測期間の市場成長を促進すると予想されます。

抑制要因

機器と手技の高コスト

高コストや、血栓や出血など補助人工心臓の使用に伴う重大な合併症などの要因が、補助人工心臓の世界市場の成長を抑制しています。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 心疾患と心不全の負担増加
      • YY年
    • 抑制要因
      • 機器と手技のコストが高い
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • ロシア・ウクライナ戦争の影響分析
  • DMI意見

第6章 COVID-19分析

第7章 製品タイプ別

  • 左室補助循環装置
  • 右室補助循環装置
  • 両心室アシストデバイス

第8章 デザイン別

  • 植込み型補助人工心臓
  • 経皮的補助人工心臓

第9章 用途別

  • 候補治療への橋渡し
  • 移植への橋渡し療法
  • 回復への橋渡し療法
  • 目的地治療

第10章 エンドユーザー別

  • 病院
  • 外来手術センター
  • 専門クリニック
  • その他

第11章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ

第12章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第13章 企業プロファイル

  • Abbott Laboratories
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • Abiomed Inc
  • Berlin Heart GmbH
  • Medtronic Plc
  • Jarvik Heart, Inc
  • EVAHEART, INC.
  • Cirtec
  • CorWave SA
  • Calon Cardio-Technology Ltd
  • Teleflex Incorporated.

第14章 付録

目次
Product Code: MD1889

Overview

A ventricular assist device (VAD) is a mechanical pump that is used to support heart function and blood flow in people with weak or failing hearts. It is used either to partially or to completely replace the function of a failing heart.

VADs are designed to assist either the right ventricle (RVAD) or the left ventricle (LVAD) or to assist both ventricles (BiVAD). By relieving the heart's workload, a VAD can prolong life and improve symptoms such as fatigue and breathlessness.

Market Dynamics: Drivers & Restraints

Increasing cardiac disease and heart failure burden

The increase in the number of cardiac diseases and the increase in the heart failure burden is expected to drive the market growth. These factors increase the demand for ventricular assist devices. Additionally, the increase in technological advancements and the increase in the approvals of the devices are also expected to drive the market.

For instance, according to the report published in 2022, it is estimated that heart failure has an estimated prevalence of 26 million people worldwide and contributes to increased healthcare costs worldwide. Heart failure remains a highly prevalent disorder worldwide with a high morbidity and mortality rate.

Additionally, according to the report published in the Journal of the American College of Cardiology, high systolic blood pressure remains the leading modifiable risk factor globally for attributable premature cardiovascular deaths, which was about 10.8 million cardiovascular deaths and 11.3 million deaths overall in 2021, and has been particularly linked to ischemic heart disease and stroke-related deaths. Thus, the above factors are expected to drive the market growth in the forecast period.

Restraint

High costs of devices and the procedures

Factors such as high cost and serious complications involved with the usage of ventricular assist devices such as blood clots and bleeding, are restricting the global ventricular assist devices market growth.

Segment Analysis

The global ventricular assist devices market is segmented based on product type, design application, end-user and region.

Left ventricular assist device segment accounted for 48.3% of the market share

The left ventricular assist devices segment is expected to hold a dominant share in the global ventricular assist devices market because of the advantages of the LAVD over other types. The left ventricular assist device (LVAD) is the most common device applied to a defective heart (it is sufficient in most cases.

Left Ventricular Assist Devices (LVADs) are mechanical devices that are implanted in patients with advanced heart failure, help the heart pump blood more effectively, and could benefit patients with advanced heart failure as they await donors. They improve the function of the kidneys, liver, brain, and other organs by increasing blood flow to the body.

Left Ventricular Assist Device (LVAD) helps the left side of the heart pump blood to a large blood vessel called the aorta and to the rest of the body.

Additionally, the increase in the number of heart diseases, an increase in the geriatric population, and the increase in the number of launches of the devices are expected to drive the segment's growth. Thus, the above factors are expected to hold a significant position in the market share.

Geographical Analysis

North America is expected to hold a significant position in the global ventricular assist devices market share

North America holds a dominant share in the ventricular assist devices market share owing to technological advancements and, an increase in the burden of heart diseases and is expected to continue throughout the forecast period.

For instance, according to the report by CDC in 2021, heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States. One person dies every 33 seconds in the United States from cardiovascular disease and about 695,000 people in the United States died from heart disease in 2021.

According to the report by the Centers for Disease Control & Prevention (CDC) in 2023, it is estimated that about 805,000 people in the United States have a heart attack every year. Among these, 605,000 are a first heart attack and 200,000 happen to people who have already had a heart attack.

Thus, an increase in the burden of heart diseases, and also increase in the advancements in the region, and the presence of major companies in the region are expected to drive market growth in the region.

COVID-19 Impact Analysis:

The COVID-19 has impacted the ventricular assist devices market negatively. The reduction in the number of cardiovascular surgeries and the closure of hospitals during the period of lockdown has impacted the market growth. People refused to visit hospitals for treatment procedures because of the spread of the virus. Thus, COVID-19 has reduced the growth of the market.

Competitive Landscape

The leading companies with a significant market share include: Abbott Laboratories, Abiomed Inc, Berlin Heart GmbH, Medtronic Plc, Jarvik Heart, Inc., EVAHEART, INC., Cirtec, CorWave SA, Calon Cardio-Technology Ltd, and Teleflex Incorporated.

Key Developments

  • On June 20, 2023, CorWave declared that its Series C round has brought in a total of $64 million to fund entry into clinical trials and initial manufacturing of its wave membrane LVAD.
  • On January 6, 2022, the IIT Kanpur has forayed into the field of medical technology with its ambition of creating the world's most advanced Left Ventricular Assist Device (LVAD).

Why Purchase the Report?

  • To visualize the global ventricular assist devices market segmentation based on product type, design, application, end-user and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of ventricular assist devices market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global ventricular assist devices market report would provide approximately 69 tables, 68 figures, and 185 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Design
  • 3.3. Snippet by Application
  • 3.4. Snippet by End-User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing cardiac disease and heart failure burden
      • 4.1.1.2.
    • 4.1.2. Restraints
      • 4.1.2.1. High costs of devices and the procedures
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Left Ventricular Assist Device *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Right Ventricular Assist Device
  • 7.4. Biventricular Assist Device

8. By Design

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Design
    • 8.1.2. Market Attractiveness Index, By Design
  • 8.2. Implantable Ventricular Assist Devices *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Transcutaneous Ventricular Assist Devices

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Bridge to Candidacy Therapy *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Bridge to Transplant Therapy
  • 9.4. Bridge to Recovery Therapy
  • 9.5. Destination Therapy

10. By End-User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.1.2. Market Attractiveness Index, By End-User
  • 10.2. Hospitals *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Ambulatory Surgical Centers
  • 10.4. Specialty Clinics
  • 10.5. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Design
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Design
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. UK
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Design
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Design
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Design
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Abbott Laboratories *
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Abiomed Inc
  • 13.3. Berlin Heart GmbH
  • 13.4. Medtronic Plc
  • 13.5. Jarvik Heart, Inc
  • 13.6. EVAHEART, INC.
  • 13.7. Cirtec
  • 13.8. CorWave SA
  • 13.9. Calon Cardio-Technology Ltd
  • 13.10. Teleflex Incorporated.

LIST NOT EXHAUSTIVE.

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us